<DOC>
	<DOC>NCT02506569</DOC>
	<brief_summary>The investigation is designed to provide supporting evidence for the clinical safety of the Biotronik's new Implantable Cardioverter Defibrillator systems when used under specific 3 Tesla MR conditions .</brief_summary>
	<brief_title>ProMRI 3T ENHANCED Master Study</brief_title>
	<detailed_description />
	<criteria>Implanted with Implantable Cardioverter Defibrillator (ICD) system according to Clinical Investigational Plan (CIP) ICD system was implanted in the pectoral region Implantation at least 5 weeks prior to enrollment date Patient body height ≥ 140 cm Age ≥ 18 years Right Ventricular pacing threshold (at 0.4 ms) measurable and ≤ 2.0 V Written informed consent Able and willing to complete MRI testing Able and willing to complete all testing required by the clinical protocol Available for all followup visits at the investigational site Standard contraindication for MRI scans Patient shows signs of a twiddler's syndrome, i.e. fiddles with implant Explantation, exchange or reposition of ICD or lead within 5 weeks prior to enrollment date Charging status of the battery is Elective Replacement Indicator (ERI) or End of Service (EOS) MRI scan within 5 weeks prior to enrollment date Rwave sensing amplitude &lt; 6.5 millivolt Lead impedance less than 200 or greater than 1500 Ohm Life expectancy of less than six months Cardiac surgery in the next six months Pregnant or breastfeeding Participation in another interventional clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>